U.S. approval of pharma companies' COVID-19 vaccine development handling 2021

Published by
Matej Mikulic,
Oct 14, 2022
According to a survey conducted in March 2021 among U.S. adults, around 75 percent of respondents stated that they either strongly approve or somewhat approve of how pharmaceutical companies handled the development of the COVID-19 vaccinations. This statistic illustrates the percentage of U.S. likely voters who approve of how pharmaceutical companies handled COVID-19 vaccine development.

Percentage of U.S. adults who approve of how pharmaceutical companies handled COVID-19 vaccine development as of 2021

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

April 2021

Region

United States

Survey time period

March 24-26, 2021

Number of respondents

1,225 respondents

Age group

18 years and older

Special properties

likely voters

Method of interview

Online survey

Supplementary notes

Original question: "Do you approve or disapprove of how pharmaceutical companies like Pfizer, Moderna, and Johnson & Johnson handled vaccine development in response to the pandemic?"

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " U.S. pharmaceutical industry "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you U.S. pharmaceutical industry

Contribution to global pharma

5

Overview

6

Companies

6

Research and development

7

Generics

5

Public view on pharma

6

Outlook

4

Further related statistics

18

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical research and development (R&D)Global pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsCoronavirus (COVID-19) vaccines and treatments
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu